Skip to main content

Advertisement

Table 2 Levels of serum HBV RNA at baseline and on-treatment: relationship to response at 24 weeks posttreatment

From: Serum hepatitis B virus RNA levels as a predictor of HBeAg seroconversion during treatment with peginterferon alfa-2a

  HBV RNA (copies/mL) Total No. of patients No. of patients with HBeAg seroconversion Percentage of patients with HBeAg seroconversion
Baseline 200,000 25 14 56.0%
> 200,000 36 8 22.2%
Week 12 3000 20 15 75.0%
> 3000 41 7 17.1%
Week 24 1000 17 12 70.6%
>  1000 44 10 22.7%
  1. HBV RNA hepatitis B ribonucleic acid